Terms: = Uterine cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Prognosis
5 results:
1. Serous endometrial intraepithelial carcinoma (SEIC): Current clinical practice in The Netherlands.
Slaager C; Hofhuis W; Hoogduin K; Ewing-Graham P; van Beekhuizen H
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():25-29. PubMed ID: 34416579
[TBL] [Abstract] [Full Text] [Related]
2. Expression profiling and significance of VEGF-A, VEGFR2, vegfr3 and related proteins in endometrial carcinoma.
Wang J; Taylor A; Showeil R; Trivedi P; Horimoto Y; Bagwan I; Ewington L; Lam EW; El-Bahrawy MA
Cytokine; 2014 Aug; 68(2):94-100. PubMed ID: 24845798
[TBL] [Abstract] [Full Text] [Related]
3. Angiogenesis and expression of angiogenic agents in uterine and ovarian carcinosarcomas.
Näyhä V; Stenbäck F
APMIS; 2008 Feb; 116(2):107-17. PubMed ID: 18321361
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis.
Schoppmann SF; Birner P; Stöckl J; Kalt R; Ullrich R; Caucig C; Kriehuber E; Nagy K; Alitalo K; Kerjaschki D
Am J Pathol; 2002 Sep; 161(3):947-56. PubMed ID: 12213723
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma.
Yokoyama Y; Sato S; Futagami M; Fukushi Y; Sakamoto T; Umemoto M; Saito Y
Gynecol Oncol; 2000 Jun; 77(3):413-8. PubMed ID: 10831352
[TBL] [Abstract] [Full Text] [Related]
